Solta Medical, a division of Valeant Pharmaceuticals International, Inc., announced that its Thermage FLX System has received FDA clearance to non-invasively smooth skin on the face, eyes and body. The FLX is the newest generation of Thermage, a treatment favored by celebrities such as Gwyneth Paltrow, Demi Moore, and Oprah Winfrey, which uses patented radiofrequency technologies to create a uniform heating effect in the deep collagen-rich layers of the skin, tightening existing collagen and stimulating the production of new collagen. The Thermage FLX features a new optimized energy delivery algorithm, which automatically measures and precisely tunes the amount of energy delivered to the patient and treatment area. The system also features a new vibrating hand-piece to help enhance patient comfort, and a new, larger treatment tip that reduces treatment time by 25 percent.
“As the demand for skin tightening procedures continues to rise, we have continued to evolve and enhance our Thermage technology to meet the needs of skincare physicians and their patients who are looking for ways to achieve smoother skin with natural looking results,” said Joseph C. Papa, chairman and CEO, Valeant. “With the approval of the Thermage FLX through our Solta business, a pioneer and leader in the aesthetic industry, treatments are now faster and more patient-friendly.” The new Thermage FLX system is expected to be commercially available before the end of 2017.